Valproate‐induced parkinsonism: Use of a newer pharmacovigilance tool to investigate the reporting of an unanticipated adverse event with an “old” drug
- 9 March 2005
- journal article
- letter
- Published by Wiley in Movement Disorders
- Vol. 20 (3) , 387
- https://doi.org/10.1002/mds.20357
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- Reversible parkinsonism with normal β-CIT-SPECT in patients exposed to sodium valproateNeurology, 2004
- Safety Related Drug-Labelling ChangesDrug Safety, 2004